To Study the effects of Unani Formulation Joshanda Aftimoon in patients with Generalized Anxiety Disorder
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2023/03/050663
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Clinically diagnosed patients of Izterab-i-Nafsani Umoomi
Patients in age group of 18 to 65 years
Irrespective of gender
Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily.
Panic disorder, Obsessive Compulsive disorder, Post-traumatic stress disorder,etc.
Patients below 18 years and above 65 years.
History of substance abuse : Caffeine, Alcohol, Drug intoxication.
Patient who fails to follow up.
Patient who fails to give written consent.
Known cases of Hyperthyroidism, Cardiovascular disease, Renal disease and Liver disease.
Pregnant and lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Hamilton Anxiety Rating Scale (HAM-A)24 <br/ ><br>2.Anxiety State Test (AST)- State-Trait Anxiety Inventory (STAI)23 <br/ ><br>3.Beck Anxiety Inventory (BAI)32Timepoint: 40 Days
- Secondary Outcome Measures
Name Time Method 1.Vegetative manifestations (increased heart rate, diaphoresis, tremor, or dry mouth) <br/ ><br>2.Symptoms in the chest or abdomen (respiratory symptoms, feeling of tightness, chest pain, abdominal discomfort) <br/ ><br>3.Mental symptoms (dizziness, derealization, fear of losing control, fear of dying) <br/ ><br>4.General symptoms (hot or cold flashes, paresthesias) <br/ ><br>5.Symptoms of tension (muscle tension, agitation, foreign-body sensation in throat) <br/ ><br>6.Other nonspecific symptoms(exaggerated startle response, lack of concentration, irritability, difficulty falling asleep)Timepoint: 40 Days